AI Insight
Researchers from UCL and University of Cambridge have developed an AI-based computer model that uses individual patients' genetic profiles to predict which treatments might effectively target their cancers, particularly in cases where standard therapies have failed. The treatment-predicting program analyzes detailed genetic fingerprints to identify potential therapeutic options for hard-to-treat cancers. The findings were published in Cell Reports Medicine.
Why it matters
This approach could provide personalized treatment options for patients with cancers that do not respond to conventional therapies, potentially improving outcomes in difficult cases. The model represents a step toward precision oncology by matching individual genetic characteristics with effective treatments.
Understand the Science
In a new paper published in Cell Reports Medicine, the UCL team outlines how they, in collaboration with a University of Cambridge team, developed a new type of treatment-predicting computer program that uses an individual’s detailed genetic fingerprint to explore which treatments, if any, may kill their cancer—especially when standard treatments have failed.
Source: AI-based computer model offers new weapon against hard-to-treat cancers